Abstract Brachytherapy (BT), using low-dose-rate (LDR) permanent seed implantation or
high-dose-rate (HDR) temporary source implantation, is an acceptable treatment option for …

High dose-rate (HDR) brachytherapy involves delivery of a high dose of radiation to the
cancer with great sparing of surrounding organs at risk. Prostate cancer is thought to be …

Background We report the outcome of a phase I/II clinical trial of stereotactic body radiation
therapy (SBRT) for low (LR) and select intermediate risk (IR) prostate cancer (PCa) patients …

Abstract Three-dimensional (3D) transrectal ultrasound (TRUS) is utilized in prostate cancer
diagnosis and treatment, necessitating time-consuming manual prostate segmentation. We …

Brachytherapy has become an essential pillar in all-stages of localized prostate cancer,
where dose escalation has been demonstrated to improve outcome. HDR brachytherapy …

The ONE SHOT trial is the first phase I/II prospective, multicenter, single-arm study
assessing the efficacy and safety of a single-dose SBRT for men with localized prostate …

The aim of this article is to review and present the published data on high dose rate (HDR)
brachytherapy as monotherapy in the treatment of localised prostate cancer. A search and …

With over a decade׳ s worth of clinical experience to guide stereotactic body radiotherapy
(SBRT) for the treatment of clinically localized prostate cancer (PCa), sufficient data exist for …

Purpose To report the toxicity and preliminary clinical outcomes of a prospective trial
evaluating 19-Gy, single-fraction high-dose-rate (HDR) brachytherapy for men with low-and …

Background and purpose To evaluate the oncological outcome of a three-implant high dose
rate (HDR) brachytherapy (BRT) protocol as monotherapy for clinically localised prostate …